Celularity and Arthrex Enter into Exclusive Supply and Distribution Agreement for Multiple Commercial Products
GX and its directors and officers may be deemed participants in the solicitation of proxies of GXs stockholders in connection with the Business Combination.
- GX and its directors and officers may be deemed participants in the solicitation of proxies of GXs stockholders in connection with the Business Combination.
- Forward-looking statements may include, but are not limited to, statements regarding the parties expectations, hopes, beliefs, intentions, or strategies regarding the future.
- These risks and uncertainties may be amplified by the COVID- 19 pandemic, which has caused significant economic uncertainty.
- Additional risks and uncertainties are identified and discussed in the parties reports filed with the SEC and available at the SECs website at http://www.sec.gov.